References
Waldmann TA, Steinfeld JL, Dutcher TF, Davidson JD, Gordon RS. The role of the gastrointestinal system in “idiopathic hypoproteinemia.” Gastroenterology 1961;41:197–207.
Huber R, Semmler G, Mayr A, Offner F, Datz C. Primary intestinal lymphangiectasia in an adult patient: a case report and review of literature. World J Gastroenterol. 2020;26:7707–7718. https://doi.org/10.3748/wjg.v26.i48.7707.
Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann’s disease). Orphanet J Rare Dis. 2008;3:5. https://doi.org/10.1186/1750-1172-3-5.
Freeman HJ, Nimmo M. Intestinal lymphangiectasia in adults. World J Gastrointest Oncol. 2011;3:19–23. https://doi.org/10.4251/wjgo.v3.i2.19.
Kwon Y, Kim ES, Choe YH, Hyun D, Kim MJ. Therapeutic lymphatic embolization in pediatric primary intestinal lymphangiectasia. Yonsei Med J. 2021;62:470–473. https://doi.org/10.3349/ymj.2021.62.5.470.
Chamouard P, Nehme-Schuster H, Simler J-M. Videocapsule endoscopy is useful for the diagnosis of intestinal lymphangiectasia. Digest Liver Dis. 2006;38:699–703.
Cammarata SK, Brush RE, Hyzy RC. Chylothorax after childbirth. Chest. 1991;99:1539–1540. https://doi.org/10.1378/chest.99.6.1539.
Jeffries GH, Chapman A, Sleisenger MH. Low-Fat Diet in Intestinal Lymphangiectasia. N Engl J Med. 1964;270:761–766. https://doi.org/10.1056/NEJM196404092701503.
Nancy You YQ, Ling PR, Qu JZ, Bistrian BR. Effects of medium-chain triglycerides, long-chain triglycerides, or 2-monododecanoin on fatty acid composition in the portal vein, intestinal lymph, and systemic circulation in rats. JPEN J Parenter Enteral Nutr. 2008;32:169–175. https://doi.org/10.1177/0148607108314758.
Shah ND, Limketkai BN. The use of medium-chain triglycerides in gastrointestinal disorders. Pract Gastroenterol. 2017;160:20–8.
Kwon Y, Kim MJ. The update of treatment for primary intestinal lymphangiectasia. Pediatr Gastroenterol Hepatol Nutr. 2021;24:413–422. https://doi.org/10.5223/pghn.2021.24.5.413.
Makrilakis K, Pavlatos S, Giannikopoulos G, Toubanakis C, Katsilambros N. Successful octreotide treatment of chylous pleural effusion and lymphedema in the yellow nail syndrome. Ann Intern Med. 2004;141:246–247. https://doi.org/10.7326/0003-4819-141-3-200408030-00028.
Adair D, Rabah R, Ladino-Torres M, Saba TG. Case Report: A relatively mild presentation of unilateral congenital pulmonary lymphangiectasia. Front Pediatr. 2021. https://doi.org/10.3389/fped.2021.657473.
Bellini C, Boccardo F, Campisi C, Bonioli E. Congenital pulmonary lymphangiectasia. Orphanet J Rare Dis. 2006;1:43. https://doi.org/10.1186/1750-1172-1-43.
Adams DM, Trenor CC, Hammill AM et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016;137:e20153257. https://doi.org/10.1542/peds.2015-3257.
Kwon Y, Kim ES, Choe YH, Kim MJ. Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature. BMC Pediatr. 2021;21:21. https://doi.org/10.1186/s12887-020-02447-5.
Lee SY, Yang SR, Lee KR. Congenital pulmonary lymphangiectasia with chylothorax. Asian Cardiovasc Thorac Ann. 2002;10:76–77. https://doi.org/10.1177/021849230201000122.
Ruggeri G, Destro F, Maffi M, Gregori G, Lima M. A rare case of chylothorax due to pulmonary lymphangiectasia in a 7-year-old boy. Eur J Pediatr Surg Rep. 2013;1:18–20. https://doi.org/10.1055/s-0033-1337111.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Norman, J.S., Testa, S., Wang, C.X. et al. Milky Way: Management of Primary Intestinal Lymphangiectasia. Dig Dis Sci 68, 3872–3877 (2023). https://doi.org/10.1007/s10620-023-08077-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-023-08077-y